Trending...
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide - 112
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide - 111
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media - 109
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neovasc Inc. ("Neovasc" or "the Company") (NASDAQ: NVCN) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Neovasc filed a comprehensive Q-Sub submission to the FDA for its product Neovasc Reducer on December 20, 2018. On October 28, 2020, the Company announced that the FDA voted that the Reducer is safe when used as intended, but also voted against issuing a reasonable assurance of effectiveness. Based on this news, shares of Neovasc fell sharply, including a drop of more than 17% in intraday trading on October 30, 2020.
More on The Californer
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Neovasc filed a comprehensive Q-Sub submission to the FDA for its product Neovasc Reducer on December 20, 2018. On October 28, 2020, the Company announced that the FDA voted that the Reducer is safe when used as intended, but also voted against issuing a reasonable assurance of effectiveness. Based on this news, shares of Neovasc fell sharply, including a drop of more than 17% in intraday trading on October 30, 2020.
More on The Californer
- California: Governor Newsom launches new initiatives to partner with tech policy experts and accelerate responsible AI in state government
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Filed Under: Business
0 Comments
Latest on The Californer
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Inboox.ai Launches Searchable Library of Real Marketing Emails Powered by AI Analysis
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- California continues to lead the nation in fusion energy, investing in technology of the future
- Felicia Allen Hits #1 Posthumously with "Christmas Means Worship"
- CCHR Documentary Probes Growing Evidence Linking Psychiatric Drugs to Violence
- IEI Introduces HTB-300-MTL-H: Ultra-Compact Medical AI Embedded System
- Mesa West Capital Funds $30 MM Loan for Acquisition of Industrial Asset in San Francisco Bay Area
- 40th Annual California Strawberry Festival Accepting Applications for Arts & Crafts Vendors
- Play with Purpose: Meemzy Magic Sensory Kits Support Child Development in a Fun Format
- California: Governor Newsom announces top former CDC officials to lead public health innovation, collaboration
- Tokenized Real-World Assets: Iguabit Brings Institutional Investment Opportunities to Brazil
- MEX Finance meluncurkan platform keuangan berbasis riset yang berfokus pada data, logika, dan efisiensi pengambilan keputusan investasi
- Celebrate Festively with Christmas Eyeglasses
- 'The Ambony' 2026 Media Kit Is Here
- California: Governor, First Partner statement on the death of Rob Reiner, Michele Singer Reiner
- From MelaMed Wellness to Calmly Rooted: A New Chapter in Functional Wellness
- Strengthening Worksite Security: Countrywide Rental Introduces Premium Fencing in Aliceville
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- TOMORROW: Governor Newsom to make announcement with former CDC officials to expand California's science-based public health leadership